<SEC-DOCUMENT>0000721371-25-000053.txt : 20250612
<SEC-HEADER>0000721371-25-000053.hdr.sgml : 20250612
<ACCEPTANCE-DATETIME>20250612064701
ACCESSION NUMBER:		0000721371-25-000053
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250612
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250612
DATE AS OF CHANGE:		20250612

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		251041621

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cah-20250612.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:aff000f7-2853-4f25-970e-d7b052e8b2c0,g:01f29227-3b1e-4216-87b5-c4fae6067127,d:0ce5a720227d4ec3aea784e9f66fa69b-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cah-20250612</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0000721371</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cah-20250612.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-12</xbrli:startDate><xbrli:endDate>2025-06-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0ce5a720227d4ec3aea784e9f66fa69b_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Washington,&#160;D.C. 20549</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Current Report</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-bottom:0.5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June 12, 2025</ix:nonNumeric></ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.783%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                         </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-4">Cardinal Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:31.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.121%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.254%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-5">Ohio</ix:nonNumeric></span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">1-11373</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">31-0958666</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other<br/>jurisdiction of incorporation)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File Number)</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">7000 Cardinal Place</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Dublin</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Ohio</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">43017</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">614</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">757-5000</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:0.5pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">see</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instructions A.2. below):</span></div><div style="margin-bottom:0.5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:31.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.430%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common shares (without par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">CAH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.210%"><tr><td style="width:1.0%"/><td style="width:79.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i0ce5a720227d4ec3aea784e9f66fa69b_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01: Regulation FD Disclosure </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 12, 2025, Cardinal Health, Inc. (the &#8220;Company&#8221;) issued a press release announcing, among other things, updated fiscal year 2025 outlook and preliminary outlook for fiscal year 2026, long-term financial targets and certain strategic updates. A copy of this news release is included as Exhibit 99.1 to this report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company today will host an Investor Day beginning at 9:00 a.m. Eastern time where management will discuss the Company&#8217;s financial outlook and provide updates on the Company&#8217;s strategy and capital allocation framework. The event will be live-webcast and archived on the Company&#8217;s Investor Relations website. To access the webcast and corresponding slide presentation, visit ir.cardinalhealth.com. No access code is required.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01: Financial Statements and Exhibits </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="investorday2025pressreleas.htm">News release issued by the Company on June 12, 2025</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i0ce5a720227d4ec3aea784e9f66fa69b_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:54.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardinal Health, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 12, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/    AARON E. ALT</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aaron E. Alt</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>investorday2025pressreleas.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ifa6d3937414b4da99de89b24157b8647_1"></div><div style="min-height:42.48pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="padding-left:27pt;text-align:right"><img alt="essentialtocarea57a.jpg" src="essentialtocarea57a.jpg" style="height:78px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div><div style="padding-left:27pt;text-align:right"><font><br></font></div><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day</font></div><div style="padding-left:27pt;text-align:justify"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:130%">Key announcements&#58;</font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:130%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%">(13% growth at the mid-points)</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:130%;position:relative;top:-3.85pt;vertical-align:baseline"> 2</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY28</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:130%;position:relative;top:-3.85pt;vertical-align:baseline">3</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:130%;position:relative;top:-3.85pt;vertical-align:baseline">3,4</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Raising long-term target for Other profit to &#126;10% normalized growth</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:130%;position:relative;top:-3.85pt;vertical-align:baseline">3,4,5</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Updating GMPD long-term target to $50M+ of profit growth per year after FY26</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Expecting at least $10B in total adjusted free cash flow over next three years</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Raising baseline share repurchase plans to at least $750M per year</font></div><div style="padding-left:54pt;padding-right:22.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:22.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;padding-left:14.15pt">Company reiterating strategic priorities and providing updates across its businesses</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">DUBLIN, Ohio, June 12, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> &#8211; Cardinal Health (NYSE&#58; CAH) today will host an Investor Day beginning at 9&#58;00 a.m. ET, where management will detail its growth strategies to maximize the company&#8217;s potential for all stakeholders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;We are proud of the strong and resilient foundation we have built that enables us to deliver compelling future growth,&#8221; said Jason Hollar, Chief Executive Officer of Cardinal Health. &#8220;We look forward to highlighting the significant opportunities in front of Cardinal Health as we continue to evolve to reach our full potential.&#8221; </font></div><div style="padding-left:27pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company will also discuss its updated long-term financial outlook and capital allocation plans, with its disciplined capital allocation framework remaining unchanged. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Aaron Alt, Chief Financial Officer of Cardinal Health commented, &#8220;With the benefits of our robust cash flow generation, continued investments in the business and accelerating contributions from higher-margin businesses, we are positioning our business to deliver sustainable long-term growth and value creation.&#8221;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Strategic Updates</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cardinal Health continues to prioritize building upon the growth and resiliency of Pharmaceutical and Specialty Solutions by expanding in Specialty, accelerating its growth businesses and executing GMPD Improvement Plan initiatives.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Launching The Specialty Alliance</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The Specialty Alliance multi-specialty MSO platform will encompass the recently acquired GI Alliance, as well as the newly established Urology Alliance following the company&#8217;s broadened therapeutic reach into urology with the recent acquisitions of Urology America and Potomac Urology.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company&#8217;s MSO platforms, including The Specialty Alliance and the separately managed Navista oncology alliance, now support approximately 2,200 providers across 28 states and over 450 sites of care. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Expanding Biopharma Solutions</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cardinal Health announces continued investments in Biopharma Solutions. The Specialty Networks&#8217; PPS Analytics and SoNaR data and insights platforms, originally focused upon urology, are launching into oncology and further expanding in gastroenterology and rheumatology, in support of Cardinal Health&#8217;s manufacturer partners and practitioner customers, including physicians served by the company&#8217;s MSO platforms. Additionally, the company expects its Sonexus&#8482; Access and Patient Support &#8220;hub&#8221; platform to more than double its supported therapies by fiscal year 2028.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Investing in Core Pharmaceutical Distribution </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The Consumer Health Logistics Center (CHLC) in Ohio has begun to take delivery of inventory and will be fully operational in July 2025.&#160;The CHLC is the first step in a multi-year path towards increasing capacity and driving efficiencies across the company&#8217;s pharmaceutical distribution network.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cardinal Health also announces plans to build a new state-of-the-art forward distribution center with the latest in automation technology and is currently conducting a multi-state evaluation of potential locations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Additionally, Cardinal Health&#8217;s new customer ordering platform, Vantus HQ, has reached critical mass, enabling retail customers with enhanced capabilities for searching products, tracking orders and accessing reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Accelerating growth across Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight Logistics</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Nuclear and Precision Health Solutions plans to invest over $150 million over the next three years in support of the substantial theranostics and PET product pipeline across the industry in areas such as oncology, urology and neurology. The business announces the expansion of its cyclotron network for PET products in 11 markets across the United States and the further expansion of its Center for Theranostics Advancement, including its pharmacy dispensing and commercial capabilities.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Following the completion of the acquisition of Advanced Diabetes Supply (ADS) on April 1, at-Home Solutions has begun realizing anticipated acquisition synergies, including the distribution network integration of the ADS business, with completion expected within six months. at-Home Solutions also announces the opening of its automated Fort Worth facility and plans for further automation distribution center expansion at three additional sites, including two new distribution centers planned in the West and the Northeast.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">OptiFreight Logistics announces the expansion of its offerings within the hospital pharmacy setting, supporting the ongoing growth of the business.</font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Continued execution of the GMPD Improvement Plan </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The Global Medical Products and Distribution business continues to execute its improvement plan, which remains focused upon accelerating Cardinal Health Brand growth and driving simplification and cost optimization.  The multi-step effort builds upon the earlier progress of the GMPD improvement plan, which returned the business to positive profit and cash flow generation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Financial Updates</font></div><div style="padding-left:27pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Fiscal year 2025 guidance updates</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company is making the following updates to its fiscal year 2025 guidance&#58;</font></div><div style="padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Raising and narrowing non-GAAP diluted EPS&#58; $8.15 to $8.20, from $8.05 to $8.15 (9% growth at the mid-point)</font></div><div style="padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Raising Pharmaceutical and Specialty Solutions segment profit&#58; 12% to 13% growth, from 11.5% to 12.5% growth</font></div><div style="padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Narrowing Global Medical Products and Distribution segment profit&#58; &#126;$130 million, from $130 million to $140 million</font></div><div style="padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Raising Other</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> segment profit&#58; 19% to 21% growth, from 16% to 18% growth</font></div><div style="padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Narrowing interest and other&#58; &#126;$200 million, from $200 million to $215 million</font></div><div style="padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Narrowing non-GAAP effective tax rate&#58; &#126;23.0%, from 23.0% to 23.5%</font></div><div style="padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Raising adjusted free cash flow&#58; &#126;$2 billion, from &#126;$1.5 billion</font></div><div style="padding-left:27pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company is reiterating all other fiscal year 2025 guidance assumptions provided on May 1st, 2025.</font></div><div style="padding-left:27pt;padding-right:-40.5pt"><font><br></font></div><div style="padding-right:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Preliminary fiscal year 2026 guidance</font></div><div style="padding-right:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company is providing preliminary guidance for fiscal year 2026&#58;</font></div><div style="padding-left:4.5pt;padding-right:-40.5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.861%"><tr><td style="width:1.0%"></td><td style="width:60.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-GAAP diluted EPS</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$9.10 to $9.30 </font></div><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(+13% growth at mid-points)</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Adjusted free cash flow</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$2.75B to $3.25B</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Capital expenditures</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#126;$600M</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest and other</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#126;$275M</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-GAAP effective tax rate</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22% to 24%</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pharmaceutical and Specialty Solutions&#58;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Revenue</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11% to 13% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Reported)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10% to 12% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Normalized)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5% to 7% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Global Medical Products and Distribution&#58; </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Revenue</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3% to 5% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;$140M+</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Revenue (Reported)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26% to 28% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Reported)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25% to 27% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Revenue (Normalized)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10% to 12% growth</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Normalized)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#126;10% growth</font></div></td></tr></table></div><div style="padding-right:-40.5pt"><font><br></font></div><div style="padding-right:-40.5pt"><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Long-term targets</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company is providing updated long-term targets (fiscal years 2026 to 2028 CAGRs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">)&#58;</font></div><div style="padding-left:27pt;padding-right:-40.5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.416%"><tr><td style="width:1.0%"></td><td style="width:61.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-GAAP diluted EPS</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12% to 14% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pharmaceutical and Specialty Solutions&#58;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Revenue</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8% to 10% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Reported)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7% to 9% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Normalized)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5% to 7% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Global Medical Products and Distribution&#58;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Revenue</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2% to 4% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$50M+ of profit growth           </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">per year after FY26</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Revenue (Reported)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16% to 18% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:4.52pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Reported)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15% to 17% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Revenue (Normalized)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10% to 12% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Segment profit (Normalized)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#126;10% growth</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;Adjusted Free Cash Flow (FY26 to FY28 total)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At least $10B</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:-40.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;Share Repurchases (FY26 to FY28 total)</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At least $2.25B</font></div></td></tr></table></div><div style="padding-right:-40.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Capital deployment updates</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cardinal Health continues to deploy capital according to its disciplined capital allocation framework. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company anticipates robust cash flow generation and plans to invest at least $600 million per year in capital expenditures to drive organic growth across its businesses. Additionally, the company expects at least $750 million in baseline share repurchases each of the next 3 years, above its previous annual baseline expectation of $500 million annually.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Webcast</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cardinal Health will host a webcast today from 9&#58;00 a.m. to approximately 12&#58;00 p.m. ET. To access the webcast and corresponding slide presentation, go to the Investor Relations page at </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">ir.cardinalhealth.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">. No access code is required.  Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">About Cardinal Health </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%">Cardinal Health is a distributor of pharmaceuticals and specialty products&#59; a global manufacturer and distributor of medical and laboratory products&#59; a supplier of home-health and direct-to-patient products and services&#59; an operator of nuclear pharmacies and manufacturing facilities&#59; and a provider of performance and data solutions. Our company&#8217;s customer-centric focus drives continuous improvement and leads to innovative solutions that improve people&#8217;s lives every day. Learn more about Cardinal Health at </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;text-decoration:underline">cardinalhealth.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%"> and in our </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;text-decoration:underline">Newsroom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Contacts</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Media&#58; Erich Timmerman, Erich.Timmerman&#64;cardinalhealth.com and 614.757.8231 </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Investors&#58; Matt Sims, Matt.Sims&#64;cardinalhealth.com and 614.553.3661</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">GAAP refers to U.S. generally accepted accounting principles. This news release includes GAAP financial measures as well as non-GAAP financial measures, which are financial measures not calculated in accordance with GAAP. See &#34;Use of Non-GAAP Measures&#34; following the attached schedules for definitions of the non-GAAP financial measures presented in this news release and see the attached schedules for reconciliations of the differences between the non-GAAP financial measures and their most directly comparable GAAP financial measures.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The company does not provide forward-looking guidance on a GAAP basis as certain financial information, the probable significance of which cannot be determined, is not available and cannot be reasonably estimated. See &#34;Use of Non-GAAP Measures&#34; following the attached schedules for additional explanation.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">FY26 to FY28 CAGR&#59; as of FY25 guidance baseline.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Normalized ranges for Pharmaceutical and Specialty Solutions and Other exclude contributions from recent Integrated Oncology Network (ION), GI Alliance (GIA) and Advanced Diabetes Supply (ADS) acquisitions.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Other includes the following three operating segments&#58; Nuclear and Precision Health Solutions (NPHS), at-Home Solutions and OptiFreight Logistics, which are not significant enough individually to require reportable segment disclosure.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Cardinal Health uses its website as a channel of distribution for material company information. Important information, including news releases, financial information, earnings and analyst presentations, and information about upcoming presentations and events is routinely posted and accessible on the Investor Relations page at </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">ir.cardinalhealth.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. In addition, the website allows investors and other interested persons to sign up automatically to receive email alerts when the company posts news releases, SEC filings and certain other information on its website.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Cautions Concerning Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as &#34;expect,&#34; &#34;anticipate,&#34; &#34;intend,&#34; &#34;plan,&#34; &#34;believe,&#34; &#8220;will,&#34; &#34;should,&#34; &#34;could,&#34; &#34;would,&#34; &#34;project,&#34; &#34;continue,&#8221; &#34;likely,&#34; and similar expressions, and include statements reflecting future results or guidance, statements of outlook and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include the risk that we may fail to achieve our strategic objectives, including the continued execution of the GMPD Improvement Plan initiatives, whether as a result of tariffs on products we source or manufacture, an uncertain global economic environment, Cardinal Health Brand sales or ongoing inflationary pressures&#59; competitive pressures in Cardinal Health's various lines of business, including the risk that customers may reduce purchases made under their contracts with us or terminate or not renew their contracts, whether due to price increases or otherwise&#59; our ability to manage uncertainties associated with the pricing of branded pharmaceuticals, including as a result of legislative or executive actions&#59; risks associated with litigation matters, including a Department of Justice investigation focused on potential violations of the Anti-Kickback Statute and False Claims Act&#59; the risk that events outside of our control, such as weather or geopolitical events, may impact demand for our products or may cause supply shortages that impact our cost and ability to fulfill customer demand&#59; the performance of our generics program, including the amount or rate of generic deflation and our ability to offset generic deflation and maintain other financial and strategic benefits through our generic sourcing venture or other components of our generics programs&#59; risks associated with recently completed and pending acquisitions, including risks arising as a result from our entry into new lines of businesses.. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8K reports and exhibits to those reports. This release reflects management&#8217;s views as of June 12, 2025. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Forward-looking statements are aspirational and not guarantees or promises that goals, targets or projections will be met, and no assurance can be given that any commitment, expectation, initiative or plan in this report can or will be achieved or completed. Cardinal Health provides definitions and reconciliations of non-GAAP financial measures and their most directly comparable GAAP financial measures at ir.cardinalhealth.com</font></div><div><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cah-20250612.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:aff000f7-2853-4f25-970e-d7b052e8b2c0,g:01f29227-3b1e-4216-87b5-c4fae6067127-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cah="http://www.cardinal.com/20250612" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20250612">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20250612_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20250612_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cardinal.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cah-20250612_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:aff000f7-2853-4f25-970e-d7b052e8b2c0,g:01f29227-3b1e-4216-87b5-c4fae6067127-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5695098e-2c65-4b60-a57d-78c8c6dce141_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_20d83a94-ff07-4573-83bc-d0533665bf7f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1454629d-b83a-48de-8f23-ce195b4a5616_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_055e736c-4ea3-45e9-af1e-f5c545f12bef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_50c1c6b2-e907-42c0-ac8c-67dc0b12a23b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_6c090260-e487-45ef-bea1-421ebe400019_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cd57c2a6-2e37-44fe-8d68-c301c93ebbfe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_986de53c-fb8f-4c06-9b92-66c035e02e23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_33159066-8bae-4950-becd-c314eb12d438_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d9b320b7-0d2a-45bb-815e-a1d7e5ef7db1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_50b1527a-e2e9-4a29-808e-adadd6f987ad_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_9f798015-8402-4c18-848a-92d613e4f0e9_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3fef59c0-22dc-44bb-b399-c80b168023c7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_32a94513-697a-48e7-bb62-abdec486f448_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5274950c-45ab-4e97-bc49-b045abe4c4a5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_75fd8f11-4866-4398-8900-0f70c8a7b63e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a82a964a-be11-4f8a-a123-aef88fc55bc3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8f70bfd8-146e-4e69-958f-58ec54d9bc8c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_bb2f2c2f-bdc0-43b3-a2fa-3ea74afa86cc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7d1329c8-5b06-4e1b-a445-2c93bc0207d1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_1ae32f74-08a1-4a68-a40b-8a0addfa22de_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ef23193f-a839-488a-a0d1-3957c649a336_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6a02b8b4-a919-46c9-b1db-068a4a05d9e4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cah-20250612_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:aff000f7-2853-4f25-970e-d7b052e8b2c0,g:01f29227-3b1e-4216-87b5-c4fae6067127-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:type="simple" xlink:href="cah-20250612.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_65ea71a3-3c88-4188-9261-1caa3b37dfbc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_DocumentType_65ea71a3-3c88-4188-9261-1caa3b37dfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_04f009b6-18c2-466a-8a85-38670340b510" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_DocumentPeriodEndDate_04f009b6-18c2-466a-8a85-38670340b510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e0ef9122-865e-4527-8fa2-615c7455b7b5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityRegistrantName_e0ef9122-865e-4527-8fa2-615c7455b7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b285455b-fc81-4210-be9c-8e8f47e13c80" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b285455b-fc81-4210-be9c-8e8f47e13c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_56bf8d77-c726-4e2b-a892-bd6e98f169f0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityFileNumber_56bf8d77-c726-4e2b-a892-bd6e98f169f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_26d9476a-cdd3-4f95-96cd-837094a75639" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityTaxIdentificationNumber_26d9476a-cdd3-4f95-96cd-837094a75639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ac959ae9-1116-4263-937d-f170f50e0d84" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityAddressAddressLine1_ac959ae9-1116-4263-937d-f170f50e0d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_dd42c409-d41e-46ae-a4b8-cba39512d014" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityAddressCityOrTown_dd42c409-d41e-46ae-a4b8-cba39512d014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b8dbe004-4a82-4d5a-9a64-7616bdd41972" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityAddressStateOrProvince_b8dbe004-4a82-4d5a-9a64-7616bdd41972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8d6c20ba-4bc5-4742-9b06-3e0b44813c05" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityAddressPostalZipCode_8d6c20ba-4bc5-4742-9b06-3e0b44813c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ff948cc1-e3cb-467f-899d-faf6397ad3fe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_CityAreaCode_ff948cc1-e3cb-467f-899d-faf6397ad3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_42f42334-db33-4319-9163-c3ca2218241a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_LocalPhoneNumber_42f42334-db33-4319-9163-c3ca2218241a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_54b41e1c-6fa6-43e3-a325-06999b043ab5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_WrittenCommunications_54b41e1c-6fa6-43e3-a325-06999b043ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_bc86e216-b4da-4290-a223-dc5c665cdaf0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_SolicitingMaterial_bc86e216-b4da-4290-a223-dc5c665cdaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_d8d4b6a9-37ba-4735-8a77-a6934f158618" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_PreCommencementTenderOffer_d8d4b6a9-37ba-4735-8a77-a6934f158618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_099cbe0f-4eeb-4247-a0dd-5fef2395f904" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_099cbe0f-4eeb-4247-a0dd-5fef2395f904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ed76c3f3-1993-48fb-a60d-77bcb85fbe19" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_Security12bTitle_ed76c3f3-1993-48fb-a60d-77bcb85fbe19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8b04ad61-6a73-4a6a-9f74-af28e710a083" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_TradingSymbol_8b04ad61-6a73-4a6a-9f74-af28e710a083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2eca5a4c-3945-4667-a9b5-cc3930c68a29" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_SecurityExchangeName_2eca5a4c-3945-4667-a9b5-cc3930c68a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_09020d03-50a8-41e0-8360-940865c2391e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityEmergingGrowthCompany_09020d03-50a8-41e0-8360-940865c2391e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ec53f181-a528-42d0-9fd9-1226cdfa2dd0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_EntityCentralIndexKey_ec53f181-a528-42d0-9fd9-1226cdfa2dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_02545848-da3a-40b8-b16a-30663390f06a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7053c782-d623-4113-aeb0-76be5a195b72" xlink:to="loc_dei_AmendmentFlag_02545848-da3a-40b8-b16a-30663390f06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>essentialtocarea57a.jpg
<TEXT>
begin 644 essentialtocarea57a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !M 0<# 2(  A$! Q$!_\0
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M8^P)K15(-V3.2>#KPCSS@TN[3L:E%%%6<P4444 %%%% !1110 4444 %%%%
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M47^.,6^Y\_\ P]^/WQ-\0V(M_A9^S#)X,T>3[EYXPU&T\-QI[FSMTFG(_P"
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M3XFW'BKXV>.[[4[S4O&5O<SW=W#I_P!J_<Q02W(WK*[3+&'(R@B;;C((PO\
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MBW\2/8^(;K4I)-2LS!;JT)CF)W+L/*XZ5\S_ /!.KP3^W'_P5H_9&UB?P_\
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M /285R__  0/7P%'_P %^?B;'\+8H(?AQ!I&OP^&UAD>2+["EW:K$R,Y+,I
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M1?\ TN-2_L12JO\ P6O_ &SHRRB0V'@]PA/S%?L$O./3WI@>,^,OV?\ Q/\
MM)?\'!?QC\.Z/\1O%/PV\/CX<:)<:_=>&94MM8U&)7 BMH;EE8VZER6=T&XA
M H(#$UZ1\'6\>_\ !/;_ (*I>!?@I+\3O&_Q0^%GQI\-ZGJ6F0^,KX:EJOAK
M4-/59)/+NB [P2(WW6Z%O;)T?@!_RL3?'_\ [)=H'_HX5/\ MA?\IX/V/_\
ML6O&/_I)%0!]X4444 %%%% !1110 4444 %%%% 'QS^UM_P08_9D_;,\<7?B
MCQ-X#;2/$NHN9;W4O#U])I<E\YQEY4C/E.YQDL4W$DY)K=_8/_X(T_ G_@G+
MXQU7Q#\-M"UF+7=9L#I=S>ZGJTUZS6Q=7:,(Q$8!9%).W/RCFOJFB@#X1\9?
M\&VO[(OCGXO3>+[SX=74+W-T;R?2+76+F#297+;F'V=6 5&/)1"J\XP!Q7KG
M[/7_  27^!O[*O[3>K_%OP#X5G\.>+M:MIK*X%MJ$PT](93&6CCM=WE1KF),
M!5&,<=:^DJ* /G7X2?\ !*[X-?!#]L3Q%\=_#VAZI;?$CQ3)>2ZC>R:O<S02
MM=N'FQ SF-<E1C X[5Z/^U%^RGX _;-^$%_X$^)/ARS\3>&K]EE:WF+(\$JY
MV312(0\<BY.'4@\D="0?0Z* /A/X9_\ !M_^R;\+O#7BC3K7P)J.HOXLLCI]
MU>ZAK-Q/=VT!=79;>3</))*KEU <@$;L$@^V^&/^"9?PC\(?L0W_ .SQ8Z-J
M:?"[4HYHI[!]5N'N"LUQ]H<"X+>:,R<\-QTZ5[_10!X'\'_^":'PD^!7[('B
M+X%^'-&U*U^'/BI+V/4;*75+B:>47:!)\3LQD7*CC!X[5L?L2_L&?#;_ ()[
M?#&_\(?"_2[[2="U/47U6>*ZU":]=KAHTC+!Y69@-L:< XX]Z]DHH ^<OV0?
M^"5'P8_88^+/BKQM\.M"U33/$'C.%X-5FNM7N;R.9'G\]@J2N57]YSP!QQTK
MR#XB?\&W?[)'Q-^,-QXQO_AY=V\U[=&\N=*LM8N;;2IY"VY_W", JL<DJA5>
M3P*^[** /F[X#_\ !)GX&?LR?M07_P 7O OA*3PWXOU"R?3G6TOYDT^.W9(D
M,<=KN\I!B&/[JCD$]2:E^'7_  2J^#'PK_;1UCX_Z-H6J0?$S79;J:\OGU>Y
MD@=KE-DI$#.8QD=,+QVKN_A#^T)K'Q<N4OX? ^HZ9X0GDNA!KMUJ=KLFCADD
M19O)5S($D*;E)'W6!.*[$?%CPL?#EMK'_"2^'_[(O9Q;6]]_:,/V:>4D@1I)
MNVLV01M!SD&@#F? ?[*G@OX;?M$^.OBGI-C=0^,OB-;6-IKER]Y))%<1V<9C
M@"Q$[(\*QR5 SWJ/]JK]DKP3^V?\,K?PAX^L+O4M#MM4M=8CBM[R6U<7-L_F
M1-OC(; ;J,X/>NYNO&&D6/B6VT:;5-.AUB]C::WL7N46YG1<[G2,G<RC!R0,
M#!J.U\=Z'?:ZVEPZSI4VII!]J:S2[C:<0YQYA0'=LSQNQB@#G?VA_P!F_P #
M?M8?"C4O _Q$\-:;XK\+ZJ%-Q8WJ$KN4Y61&!#(ZGD.A##L:\!^"'_!%7X(_
M GXI>'/%UE_PL/Q!J7@V<77A^#Q%XTU+5;+190I57@@EE,8*J2!D' ->^Z)^
MT)X:\<:3%>^$[ZV\8P'61HDYTB[@E^R2B9HI7?<Z_)&8Y"VW+%4)4-71/X^T
M*/Q:N@-K6D+KKIYBZ:;R,7;+C.X19WXQSG'2@#Q3]LC_ ()C_"+]N?Q)H>O^
M-M'U6U\6>&D,6F>(] U:XT?5[2(DDQ"X@96,9))VMD DXQDYY_X-?\$=/@+\
M!O'7@[Q7X>\,:DGBWP7J5UJ]MKMYK5W>:EJ%U<0?9Y'O)Y79[D>5\JK(2J<E
M0"37KOA;]I7P]J'P(F^(NN75KX8\,PF[E-U>W $8MH9Y8DFS@?ZQ(PZJ 3\X
M R>O3S_$_P -6MKI4\OB'0XH==8)IKO?Q*NH,<86$EOWAY'"YZT <MH7[*G@
MSPY^U%KOQCM+&Z3QWXDT.W\.WUV;R1H9+."3S(T$).Q6#'.X#)]:\U_:%_X)
M5?"7]I#]H"V^*.J0^+O#_CF.WAM+O4_#7B2\T9]6@A8-'#="!U$R+M PPZ
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,ON^B:* "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Jun. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 12,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cah-20250612.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cah-20250612.htm">cah-20250612.htm</File>
    <File>cah-20250612.xsd</File>
    <File>cah-20250612_lab.xml</File>
    <File>cah-20250612_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cah-20250612.htm": {
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20250612",
   "dts": {
    "inline": {
     "local": [
      "cah-20250612.htm"
     ]
    },
    "schema": {
     "local": [
      "cah-20250612.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20250612_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20250612_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.cardinal.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cah-20250612.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cah-20250612.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000721371-25-000053-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-25-000053-xbrl.zip
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M?H097BAL=)(AI@K*PBM /'>B[<$3;0@D ME-\_!(&\'0&HG&<+>R!F#>R(B
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M_@!!7]BU@W:M*EPM]KFL[/M%/MK<FC/MDJ(Y)MQE-!'37]T][0QD>U2CTI$
MY]66/>-YE<?U_9=?^ .\'1-!V26L-(<:@,@D;%;@.T.M>B"&*N4_#6,51N^/
MIE&+!#%S=UOA9=]>+D]._;#!L?QH:=NBX^?X"*G<=4T]&!X+"('YUF#"Y7'*
M]/V"65)18> ,$)8[0-E;EHWTTG $@4,J,XA3X9X<!B($#EQGX8"$FGT2X- O
MS$R9;-Y !CUI!'T4.9R*(&; W J$?O^)S$3(;^.+"]O<#"ZS;;WY "XK?6M/
MQLDF[B1R])J]NF:K)")8MS1SNEE]FQ'6\H/O>ZYO6Q])_;!RN^>*@,GGB&6*
M@LW:,U0%;TN-\98=H\K[1=MKH.:MU[4Y=/CC,/;KZ(GKE._!V\-1E5?EW9]'
M1Y?G9^A$1T=?KE[:F3[/_75O0?A'F $"E%(/Q=9+_2T)MAM0XD_E>,]]G[IS
M":D?(CRM9O^'&O5_M>G\'U!+ P04    " #@-<Q:[X4!@F4"   #!P  $
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M0$RC$!*#(\@2I*%*!(JPI@)+]-/5&Q08S#!.8"@"#0D.8D@3$4%)#-<QBI/
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MX>>(=>3&+OST//H?9-T\CRR<-)4B3$)E",3)T&0$JFEPSYG"=5)6"^)[R*_
M(VY>=%J=@TWP>LMMT95PO#:<TA3GX,AS>*T\/5GE4M;GH$]A7AGT)S?0MZ8/
M^LB,3EF)Q>/3UV]/G]!DJ+HF!HB17=7/J,D@J#B4IT>,O,B482>)4WL.Q%W%
M-06<'OG$#CS :+]EY(Y;G5WD2>V]UC$3@T<)[8)P3R>6^*!&=+7T(9\58"0I
M:AJJCY#'H(2+*^!(O&6@4_?P,-%C.J@H3R5HJ,N"Y]+:UZR4PJJ48N=O-D'I
MKNEFJ=11^MJB < @&LP$PG$!;\OTML"-+?B7HN0T,W6W/KP$*A%%R91%DA$.
MX8M2%0SBTMU!@D&6) YQP<^'F>]3Y;B-GBP4I<ON?FI4%J7'O&BR$9!Y15ED
MQD^N\N#$Y-P](]H ;[!O]AZP(?XEXS2SXO4_&VQ5# ^I?$0)#ZG@$.BUX:J1
M=&/B*KN%PW<R4?& , ]7G60721#7 :E\:V$J@5_J:4@$& Q987#)-8XDS,.)
M9/_MGD"N%[]M N>7>]>3:F*6)X#.J,^R(.+>-@4BX&G@:"K%.H,HH 3">KKU
M&@RL)()TQ_M1JE\F_*C2!]ZJDEUO/J5M.QCEP.NC-M K*(G8NNB(RVMF>[YS
M2(1Q=M:%=3I#Y  <&UN JO,7'W-=$B,]<MW&BDO5L'2XCBE[!W+*&"[@PG..
MFQI%YD/CQ<K_Y?!=I:*7.RX:E>&5]6Z"($(P#2)#9?W<+[L%:25Q/+%V&P:4
M7*ITQNO_@8P<QG)1@GV.-54D5WV4CX$T_L<J-T["L?1[,*JXBV[Q<61*;G2D
M8C8L+B)3433ATFG55#?!U);KW\N%%#=2N;>F(Y5<E0YYEH3 -[*KB+N$ A$
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MXM95T7.S#:FS?D.J%KE"XW74HW 2YP3^;"LRYI+4K)]IIZM4P'&L!_&:K2/
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M[B(O $W%H8-.IW5,3?SJ179@LFAFF&#^P&3^ #CWGSD:\[5:#7Y,VQ^-]"7
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M+3(P,C4P-C$R7W!R92YX;6Q02P$"% ,4    " #@-<Q:H4?:?N<=   ]]P
M'@              @ $S(P  :6YV97-T;W)D87DR,#(U<')E<W-R96QE87,N
9:'1M4$L%!@     %  4 3 $  %9!      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>cah-20250612_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cah-20250612.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2025-06-12</startDate>
            <endDate>2025-06-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0000721371</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-06-12</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-06-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-4">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-5">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">1-11373</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">614</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">757-5000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
